中国P站

Acetaminophen toxicity; N-acetyl-p-benzoquinone imine (NAPQI); Glutathione depletion; Cytochrome P450 enzymes; Oxidative stress; Mitochondrial dysfunction; Liver injury; Hepatocellular necrosis; Reactive oxygen species; Peroxynitrite formation; Protein adducts; Lipid peroxidation; Inflammatory cytokines; JNK signaling; Apoptosis; Necrosis; Hepatic metabolism; Drug-induced liver injury; Antioxidant defense; Cellular stress response

Introduction

Acetaminophen (APAP), commonly known as paracetamol, is one of the most widely used over-the-counter analgesic and antipyretic medications globally. While generally safe at therapeutic doses, overdose can result in severe liver injury, representing a leading cause of acute liver failure (ALF) in many countries. Despite its widespread clinical use, acetaminophen possesses a narrow therapeutic index, and supratherapeutic doses initiate a cascade of biochemical events that culminate in hepatocyte necrosis. Understanding the biochemical mechanisms underlying acetaminophen-induced hepatotoxicity is essential for improving treatment strategies, designing protective interventions, and developing safer therapeutic analogs. This article delves into the metabolic pathways, molecular interactions, and cellular responses that contribute to acetaminophen-mediated liver injury, highlighting the roles of reactive metabolites, oxidative stress, and mitochondrial dysfunction [1,2].

Description

The hepatotoxicity of acetaminophen is primarily mediated through its hepatic metabolism. Under normal therapeutic conditions, the majority of acetaminophen is conjugated via phase II reactions, specifically glucuronidation and sulfation, to form water-soluble compounds excreted in urine. However, in overdose situations, these pathways become saturated, leading to a greater proportion of the drug undergoing oxidation by the cytochrome P450 enzyme system particularly CYP2E1, CYP1A2, and CYP3A4. This metabolic shift results in the formation of a highly reactive intermediate, N-acetyl-p-benzoquinone imine (NAPQI). Under normal conditions, NAPQI is detoxified by conjugation with glutathione (GSH). In overdose scenarios, GSH stores are rapidly depleted, and excess NAPQI covalently binds to cellular macromolecules, including proteins and lipids, forming toxic adducts. This initiates a series of biochemical events marked by oxidative stress, mitochondrial dysfunction, ATP depletion, and ultimately, hepatocyte necrosis [3,4].

Discussion

Role of cytochrome P450 and NAPQI formation

The bioactivation of acetaminophen to NAPQI by cytochrome P450 enzymes is a critical step in its toxicity. CYP2E1, in particular, is upregulated by ethanol and fasting, increasing susceptibility to liver injury. NAPQI is electrophilic and reacts with nucleophilic sulfhydryl groups on proteins and glutathione. In healthy individuals, sufficient GSH reserves prevent NAPQI accumulation. However, in overdose, the imbalance between NAPQI production and detoxification sets the stage for hepatotoxicity. Protein targets of NAPQI include mitochondrial proteins, cytoskeletal elements, and enzymes vital for cellular homeostasis. The adduction of these proteins disrupts cellular integrity and enzymatic function, impairing energy metabolism and ion homeostasis [5,6].

Glutathione depletion and antioxidant defense failure

Glutathione plays a central role in cellular antioxidant defense. It neutralizes free radicals, detoxifies reactive metabolites, and maintains redox balance. Acetaminophen overdose depletes GSH reserves in hepatocytes, impairing the cell’s ability to counteract oxidative stress. The depletion of GSH leads to a redox imbalance, resulting in excessive generation of reactive oxygen species (ROS). Mitochondrial electron transport chain dysfunction exacerbates ROS production, triggering lipid peroxidation, DNA damage, and further protein modification. These changes compromise mitochondrial membrane integrity, leading to mitochondrial permeability transition (MPT) and loss of membrane potential [7,8].

Mitochondrial dysfunction and peroxynitrite formation

The mitochondria are central to acetaminophen-induced liver injury. As GSH depletion and oxidative stress intensify, the mitochondrial respiratory chain becomes impaired. This dysfunction results in electron leakage and ROS overproduction. The interaction between superoxide and nitric oxide (NO) in mitochondria forms peroxynitrite, a potent oxidant that nitrates tyrosine residues in mitochondrial proteins, further impairing function. Peroxynitrite formation damages mitochondrial DNA and impairs ATP synthesis. This energy deficit, along with structural disruption, culminates in mitochondrial swelling, rupture, and release of pro-apoptotic and necrotic mediators [9,10].

JNK pathway activation and amplification of injury

Another key player in acetaminophen-induced liver damage is the c-Jun N-terminal kinase (JNK) signaling pathway. Under oxidative stress, JNK is activated and translocates to mitochondria, where it exacerbates dysfunction by binding to mitochondrial outer membrane proteins.

JNK amplifies oxidative injury through a feed-forward mechanism, enhancing ROS production, increasing peroxynitrite formation, and promoting mitochondrial permeability transition. Inhibiting JNK signaling has shown protective effects in experimental models, underlining its critical role in amplifying APAP toxicity.

Cell death pathways: necrosis vs apoptosis

While some features of acetaminophen hepatotoxicity resemble apoptosis (e.g., mitochondrial involvement), the predominant mode of cell death is oncotic necrosis. This form of cell death is characterized by cell swelling, plasma membrane rupture, and release of intracellular contents. Apoptosis, a regulated form of cell death, is not a significant contributor to acetaminophen-induced injury in vivo, though caspase activation may occur at sub-lethal doses or in certain models. The release of intracellular contents during necrosis activates innate immune responses, contributing to sterile inflammation and further liver injury.

 Inflammatory response and secondary damage

The necrotic death of hepatocytes leads to the release of damage-associated molecular patterns (DAMPs), such as HMGB1, mitochondrial DNA, and ATP, which activate Kupffer cells and other immune cells. This sterile inflammatory response contributes to secondary injury by producing pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) and additional ROS/RNS. However, inflammation also plays a role in liver repair and regeneration, and the net effect depends on the balance between injury and recovery. Modulating this response may offer therapeutic potential without suppressing essential regenerative processes.

Therapeutic interventions and clinical relevance

N-acetylcysteine (NAC) is the antidote of choice for acetaminophen toxicity. It replenishes glutathione stores, enhances non-toxic conjugation pathways, and exhibits antioxidant and anti-inflammatory properties. When administered within 8–10 hours of overdose, NAC significantly reduces liver injury and improves survival.

Recent research focuses on mitochondrial-targeted antioxidants (e.g., MitoQ), JNK inhibitors, and agents that enhance autophagy or liver regeneration. Understanding the timing and mechanisms of these interventions is crucial for clinical translation. Moreover, the identification of biomarkers such as serum microRNAs (e.g., miR-122), glutamate dehydrogenase (GLDH), and protein adducts is improving early detection and risk stratification in APAP toxicity.

Conclusion

Acetaminophen-induced hepatotoxicity exemplifies how a widely used therapeutic agent can become a potent hepatotoxin when misused. At the heart of this process is the formation of NAPQI, a reactive metabolite that overwhelms the liver’s detoxification capacity, initiating a cascade of biochemical insults. These include glutathione depletion, oxidative and nitrosative stress, mitochondrial failure, and necrotic cell death. The involvement of signaling pathways like JNK and the inflammatory response further amplify injury.

While effective treatment options like NAC exist, they are most beneficial when administered early. Ongoing research into the molecular mechanisms of toxicity is yielding promising therapeutic targets and predictive biomarkers, moving toward more personalized and proactive management of drug-induced liver injury.

By elucidating the biochemical mechanisms of acetaminophen hepatotoxicity, we gain not only insights into liver pathophysiology but also frameworks for evaluating and mitigating toxicity in other pharmacological contexts. This knowledge is essential for safeguarding public health while preserving the therapeutic value of one of medicine’s most accessible drugs.

References

1. Anderson D, Self T, Mellor IR, Goh G, Hill SJ (2007) Mol Ther 15: 2027-2036.

   , ,

2. Bellin M, Casini S, Davis RP, D'Aniello C, Haas J, et al. (2013) EMBO J 32: 3161-3175.

   , ,

3. Burridge PW, Keller G, Gold JD, Wu JC (2012) Cell Stem Cell 10: 16-28.

   , ,

4. Cao N, Liu Z, Chen Z, Wang J, Chen T, et al. (2012) Cell Res 22: 219-236.

   , ,

5. Vergara XC, Sevilla A, D'Souza SL, Ang YS, Schaniel C, et al. (2010) Nature 465: 808-812.

   , ,

6. Casimiro MC, Knollmann BC, Ebert SN, Vary JC, Greene AE, et al. (2001) Proc Natl Acad Sci USA 98: 2526-2531.

   , ,

7. Caspi O, Huber I, Gepstein A, Arbel G, Maizels L, et al. (2013) Circ Cardiovasc Genet 6: 557-568.

   , ,

8. Dubois NC, Craft AM, Sharma P, Elliott DA, Stanley EG, et al. (2011) Nat Biotechnol 29: 1011-1018.

   , ,

9. Egashira T, Yuasa S, Suzuki T, Aizawa Y, Yamakawa H, et al. (2012) Cardiovasc Res 95: 419-429.

   , ,

10. Engler AJ, Carag-Krieger C, Johnson CP, Raab M, Tang HY, et al. (2008) J Cell Sci 121: 3794-3802.

    , ,